McCamish Mark Anthony

CIK 00013907986 companiesDUBLIN 2, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001390798

Recent Transactions

50 trades

Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−33,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-12$21.00/sh−22,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-12$21.00/sh−67,025→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−60,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−50,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−11,000→ 0 total
Disposition to Issuer
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2026-02-12−42,000→ 0 total
Gift
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-04−67,025→ 0 total
Gift
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2026-02-04+67,025→ 67,025 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2025-07-29+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2025-07-29+11,000→ 22,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Ordinary Shares
2024-07-30+11,000→ 11,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2024-07-30+11,000→ 11,000 total
Award
Rafael Holdings, Inc.$RFL
Class B Common Stock, par value $.01 per share
2024-01-05$1.81/sh+27,655→ 60,241 total
Sale
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2023-12-28$14.53/sh−75,000→ 67,025 total
Sale
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2023-08-11$14.93/sh−28,975→ 142,025 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2023-08-01+33,000→ 33,000 total
Award
Rafael Holdings, Inc.$RFL
Class B Common Stock, par value $.01 per share
2023-01-05$1.84/sh+27,174→ 32,586 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2022-08-03+42,000→ 42,000 total
Award
Rafael Holdings, Inc.$RFL
Class B Common Stock, par value $.01 per share
2022-01-05$5.39/sh+5,412→ 5,412 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2021-08-03+42,000→ 42,000 total
Award
Vincerx Pharma, Inc.$VINC
Stock Option (right to buy)
2020-12-23+6,667→ 6,667 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-09-17$5.83/sh+52,398→ 171,000 total
Purchase
AVADEL PHARMACEUTICALS PLC$AVDL
ADSs
2020-09-16$5.73/sh+118,602→ 118,602 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (right to buy)
2020-09-13+50,000→ 50,000 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (Right to Buy)
2020-08-07+42,000→ 42,000 total
Disposition to Issuer
Forty Seven, Inc.
Common Stock
2020-04-07−4,595→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−327,375→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−334,239→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−184,516→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−314,395→ 0 total
Disposition to Issuer
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-07−134,629→ 0 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−27→ 134,629 total
Sale
Forty Seven, Inc.
Common Stock
2020-04-01$95.41/sh−2,340→ 34,832 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2020-04-01−30,210→ 314,395 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2020-04-01$4.88/sh+30,237→ 37,172 total
Sale
Forty Seven, Inc.
Common Stock
2020-04-01$95.42/sh−30,237→ 4,595 total
Gift
Forty Seven, Inc.
Common Stock
2020-03-16−60,719→ 0 total
Award
Forty Seven, Inc.
Stock Option (right to buy)
2019-12-13+327,375→ 327,375 total
Award
AVADEL PHARMACEUTICALS PLC$AVDL
Stock Option (right to buy)
2019-12-05+60,000→ 60,000 total
Sale
Forty Seven, Inc.
Common Stock
2019-06-25$11.02/sh−8,199→ 60,719 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2019-06-25$4.88/sh+8,199→ 68,918 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2019-06-25−8,199→ 344,605 total
Sale
Forty Seven, Inc.
Common Stock
2019-06-20$11.04/sh−8,301→ 60,719 total
Exercise/Conversion
Forty Seven, Inc.
Common Stock
2019-06-20$4.88/sh+8,301→ 69,020 total
Exercise/Conversion
Forty Seven, Inc.
Stock Option (right to buy)
2019-06-20−8,301→ 352,804 total
Sale
Forty Seven, Inc.
Common Stock
2019-05-20$12.07/sh−15,209→ 60,719 total

Companies

Recent Filings

Address

C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380

View on SEC.gov